Multiple Myeloma in Relapse study: Early Palliative Care
Official title Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma
ClinicalTrials.gov ID: NCT06485076
What this study is testing
- What it's testing
- The study wants to see if early palliative care can be used with these patients and if it helps them and their caregivers feel better and cope with symptoms. It also looks at how doctors and nurses feel about giving this care.
- Who it's for
- Adults with relapsed or refractory multiple myeloma, stage III disease, or aggressive B‑cell lymphoma, and, for lymphoma patients, their caregivers.
- What's involved
- Participants will either get usual cancer care or usual care plus early palliative care visits. They will complete questionnaires about quality of life, symptoms, mood, and satisfaction. Some will also be interviewed at the end.
- Time commitment
- The study lasts several months, with regular questionnaires and a final interview. Participants will have a few clinic visits and time to fill out surveys during the study period.
- Time commitment: about 12 months
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- (i) Age ≥18 years; (ii) A new diagnosis of multiple myeloma or at progression of disease necessitating a change in treatment plan, or...
You likely can't join if
- (i) Insufficient English literacy to complete study procedures; (ii) Hematologist-determined poor cognitive status
- (i) Age ≥18 years; (ii) Caregiver of a patient with relapsed B cell lymphoma; and (iii) Willing to attend at least 1 PCC visit with the patient.
- (i) Insufficient verbal and/or written English literacy to complete study procedures; or (ii) Patient not participating in study.
- (i) Specialized staff physician, fellow, clinical nurse specialist, or clinic nurse from the outpatient malignant hematology team or palliative care...
The study team makes the final eligibility decision.
Where it is enrolling
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Toronto, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.